Big Data Poised To Change Pharma R&D, McKinsey Suggests
Executive Summary
A McKinsey & Company white paper highlights the potential for big data gathered from across the health care spectrum to revolutionize pharma R&D.
You may also be interested in...
PCORI To Fund Development Of Data Networks For CER, Clinical Development
Patient-Centered Outcomes Research Institute plans up to $68 million in grants to develop two types of national data infrastructure, one aimed at clinical data research networks and the other at patient-powered research networks, that together can help researchers across all spectrums of health care develop robust comparative health care data.
Pfizer Research Partnership With Humana Could Inform Drug Development Decisions
Pfizer and Humana announce five-year partnership to explore ways to improve the quality, outcomes and cost of health care for seniors using medical claims data from Humana's research affiliate, Competitive Health Analytics.
Lilly Hopes To Score Novel Compounds Early By Offering To Screen Discoveries
Phenotypic Drug Discovery program is open to academia, private research labs and biotechs that could receive a report card or a deal.